GBM tissue samples (GBM1211, GBM2021) were prospectively acquired and anatomically microdissected into center (C) and margin (M) or peripheral regions followed by immunostaining for TF, TfR1, DRD5, TH, PAH, and DDC. This evidence concerns the gene PAH and glioblastoma.